Articles by Patricia Van Arnum - Pharmaceutical Executive

ADVERTISEMENT

Articles by Patricia Van Arnum

Tracking Innovation in 2013's New Molecular Entities

A review of this years crop of the new molecular entities and new biologics license applications approved by FDA thus far in 2013.
Jan 6, 2014

Patricia Van Arnhum reviews 2013's crop of the new molecular entities and new biologics license applications approved by FDA.

Evaluating Big Pharma's Manufacturing Investment Plans

The pharmaceutical majors target biologics and emerging markets in their manufacturing expansion activities and plans.
Sep 9, 2013

The pharma majors are targeting biologics and emerging markets in their manufacturing expansion activities and plans. Patricia Van Arnum reports.

US & EU Move to Strengthen Ingredients Supply Chain

The US and EU move forward with measures to fortify the pharmaceutical supply chain.
Jul 10, 2013

The US and EU move forward with measures to fortify the pharmaceutical supply chain, writes Patricia Van Arnum.

Securing the Pharma Supply Chain: Latest Initiatives

Mar 1, 2012

The problem of supply-chain security has taken center stage with a number of recent initiatives, writes Patricia Van Arnum.

Outsourcing: Strategies for Preferred-Provider Partnerships

Patricia Van Arnum examines recent examples of preferred-provider collaborations.
Feb 1, 2012

As pharma increases its level of outsourcing, its models for partnering are evolving. The highly collaborative preferred-provider relationships, for example.

ADVERTISEMENT

Click here